#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia with Lewy bodies Hereditary angioedema Anal fistula Hereditary hypophosphataemic rickets Penile cancer Palmar-plantar erythrodysaesthesia syndrome Marfan's syndrome Marginal zone lymphoma Mucopolysaccharidosis III Cataract Metastatic gastric cancer Neovascular age-related macular degeneration Autoimmune hepatitis Infantile spasms Chronic lymphocytic leukaemia refractory More trials…

    Learn about Rare Diseases

    Lymphangioma – Treatment Niemann-Pick disease – Basic Information Chondrosarcoma – Diagnostics Gaucher’s disease type III – Basic Information Behcet’s syndrome – Trials in Disease Congenital hypotransferrinaemia – Basic Information Atypical haemolytic uraemic syndrome – Basic Information Hepatic angiosarcoma – Life with Disease Kearns-Sayre syndrome – Basic Information Pulmonary sarcoidosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Baricitinib ALXN1920 Iodine (123I) Iobenguane Cldn6 Car-T(A) Apitegromab Toripalimab Ceralasertib Alternaria Alternata (402) AUR200 Galunisertib ICOTROKINRA Vafidemstat SURVODUTIDE Abelacimab Letetresgene Autoleucel VTX2735 SODIUM Anitocabtagene Autoleucel Chlorphenamine Maleate Doxycycline Annamycin More therapies…

    Learn about Your Condition

    Migraine with aura Coronary artery dissection Spinal pain Oedema peripheral Erosive oesophagitis Pancreatic failure Kidney transplant rejection Vomiting Hypersensitivity Genital herpes simplex Periodontitis Embolism Cirrhosis alcoholic Diabetic gastroparesis Procedural headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

    Recruiting

    2 1
    Investigated Diseases:
    • Atrial fibrillation
    Belgium Bulgaria Germany Hungary Italy The Netherlands +1

  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    • Sotalol
    Belgium

  • A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

    Recruiting

    2 1
    Investigated Diseases:
    • Atrial fibrillation
    Germany The Netherlands

  • Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

    Recruiting

    2 1
    Investigated Drugs:
    • AP31969 SULFATE
    Bulgaria Denmark Germany Hungary Italy The Netherlands +1

  • Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    • Atrial fibrillation
    Investigated Drugs:
    • Propafenone Hydrochloride
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    Germany The Netherlands Spain

  • Evaluation of a Single Measurement Strategy for Direct Oral Anticoagulants in Frail Older Patients with Atrial Fibrillation or Venous Thromboembolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    • Atrial fibrillation
    Investigated Drugs:
    • Apixaban
    • Lactose Monohydrate
    • Rivaroxaban
    The Netherlands
1 2 3 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!